untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-15T18:18:28Z</responseDate>
<request identifier=oai:HAL:hal-01477208v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:hal-01477208v1</identifier>
<datestamp>2018-01-11</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:IRSET</setSpec>
<setSpec>collection:UNIV-RENNES1</setSpec>
<setSpec>collection:CNRS</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:UNIV-ANGERS</setSpec>
<setSpec>collection:UPMC</setSpec>
<setSpec>collection:CIMI</setSpec>
<setSpec>collection:IFR140</setSpec>
<setSpec>collection:BIOSIT</setSpec>
<setSpec>collection:GIP-BE</setSpec>
<setSpec>collection:UR1-HAL</setSpec>
<setSpec>collection:UR1-UFR-SVE</setSpec>
<setSpec>collection:EHESP</setSpec>
<setSpec>collection:UR1-SDV</setSpec>
<setSpec>collection:STATS-UR1</setSpec>
<setSpec>collection:USPC</setSpec>
<setSpec>collection:IRSET-2</setSpec>
<setSpec>collection:UPMC_POLE_4</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=fr>Interprétation des tests sérologiques : ne pas oublier le transfert passif des immunoglobulines ! [Beware of immunoglobulin's passive transfer when interpreting serological analyses!].</title>
<creator>Pinte, Laëtitia</creator>
<creator>Vergez, Julie</creator>
<creator>Liou, Amelie</creator>
<creator>Léger, Jean-Marc</creator>
<creator>Thibault, Vincent</creator>
<contributor>CHU Pitié-Salpêtrière [APHP]</contributor>
<contributor>Centre d'Immunologie et de Maladies Infectieuses (CIMI) ; Université Pierre et Marie Curie - Paris 6 (UPMC) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Centre National de la Recherche Scientifique (CNRS)</contributor>
<contributor>Institut de recherche, santé, environnement et travail [Rennes] (Irset) ; Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )</contributor>
<description>National audience</description>
<source>Presse medicale</source>
<identifier>hal-01477208</identifier>
<identifier>https://hal-univ-rennes1.archives-ouvertes.fr/hal-01477208</identifier>
<source>https://hal-univ-rennes1.archives-ouvertes.fr/hal-01477208</source>
<source>Presse medicale, 2016, 45, pp.676-681. 〈10.1016/j.lpm.2016.03.009〉</source>
<identifier>DOI : 10.1016/j.lpm.2016.03.009</identifier>
<relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lpm.2016.03.009</relation>
<identifier>PUBMED : 27132942</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/27132942</relation>
<language>fr</language>
<subject>[SDV.EE] Life Sciences [q-bio]/Ecology, environment</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=fr>Due to their extended indications, intravenous immunoglobulins (IVIg) are increasingly used in hospital setting. After injection, classical IVIg half-life reaches more than 3weeks. IVIg result from the pooling of many blood donations and contain all natural antibodies usually found in the general population. Administered antibodies are known to interfere with many diagnostic assays, particularly those used for infectious serology. It is not recommended to perform serological determination after IVIg infusion. It is recommended to keep a delay of at least 4months after IVIg infusion before doing any serological assay; failure to do so will result in misinterpretation of biological findings. Interpretation of any serological test after IVIg administration should be particularly cautious.</description>
<date>2016</date>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
